Guilin Sanjin Pharmaceutical Co Ltd (002275 SHE) stock market data APIs

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, manufacturing, and sale of traditional Chinese medicines in China and internationally. The company offers Sanjin Tablets, Sanjinpian, Guilin Watermelon Frost, Watermelon Frost Throat Lozenges, Guilin Watermelon Frost Lozenges, Watermelon Frost Throat Clearing Lozenges, Vertigo Relief Tablets/Granules, Gecko Asthma Relief Capsules, Lamotrigine Tablets (Anxian), Naomaitai Capsules, Yuye Detoxification Granules, and Compound Tianqi Stomach Pain Capsules, Soothing Throat Spray, Guilin Watermelon Frost Capsules, NaoMaiTai Capsules, Dizziness Relief Granules, Sanqi Blood Damage Relief Capsules, Sanqi Blood Injury Relief Powder, Compound Luo Han Guo Lung-Clearing Granules, Compound Monk Fruit Lung-Clearing Syrup, Compound Red Root Herb Tablets, Shuanghu Swelling and Pain Relief, Liver and Kidney Tonifying Granules, and Jade Leaf Detoxification Granules. Its products are used in various therapeutic areas, such as urinary system diseases, oral and pharyngeal medications, throat medication, cardiovascular and cerebrovascular disease medications, nervous system diseases, respiratory disease, digestive system disease, internal medicine drugs, musculoskeletal system diseases, and tonifying drugs. Guilin Sanjin Pharmaceutical Co., Ltd. was incorporated in 2001 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.